4 Reasons Your Institution Needs an eRegulatory System
Finding new ways to more accurately and efficiently manage the regulatory compliance process is always a hot topic among researchers. […]
Finding new ways to more accurately and efficiently manage the regulatory compliance process is always a hot topic among researchers. […]
In a recent webinar, Advarra regulatory experts presented on the topic titled Institutional Responsibilities Under a Federalwide Assurance (FWA). Our
In clinical research, working with organizations that understand the ins and outs of the phase of your trial is key
The processes necessary to support regulatory compliance require valuable time and resources within a clinical research institution. Regulatory tasks in particular require frequent
In our latest webinar, a panel of experts from research organizations, Community Health Centers (CHCs) and healthcare tech discussed racial
Developing and negotiating a clinical trial budget that applies Medicare’s rules and regulations involves many challenges. Find out strategies to assist with the process.
CEO Gadi Saarony and Deb Tatton, Parexel Senior Vice President of Global Clinical Operations, consider ways to improve site and patient engagement in this Fireside Chat Q&A blog part 2.
In this Fireside Chat Q&A blog , CEO Gadi Saarony and Deb Tatton, Parexel Senior Vice President of Global Clinical Operations, share perspectives on technology’s evolving role in clinical research.
Advarra is excited to introduce Fireside Chats, a series of virtual conversations discussing current issues in clinical trials. Each Fireside Chat brings together perspectives from across the research community, enabling real-time discussion of contemporary challenges and potential solutions to help make research altogether better.
You likely have short-term projects to be completed quickly, or large ongoing projects delayed due to a lack of time and resources. We can assist with both.
One of the most complicated and multi-faceted relationships in clinical research is the relationship between sites and sponsors. As clinical
The global pandemic has changed the way we think about research. Sponsors should consider how the “new normal” will impact sites and current studies as they plan to re-start research.